Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Pedley

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Cancer Research|April 28, 2001
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complexS P Cooke, G M Boxer, L Lawrence, et al.
British Journal of Cancer|April 17, 1999
In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell linesR A Al-Mufti, R B Pedley, D Marshall, et al.
Cancer Research|July 15, 1996
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agentsR B Pedley, J A Boden, R Boden, et al.
Protein Engineering, Design & Selection : PEDS|February 20, 2009
Data standards for minimum information collection for antibody therapy experimentsM Yong, B Tolner, S Nagl, et al.
British Journal of Cancer|June 13, 2001
Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical materialS D Webley, R J Francis, R B Pedley, et al.
NMR in Biomedicine|December 19, 2014
Hepatic arterial spin labelling MRI: an initial evaluation in miceR Ramasawmy, A E Campbell-Washburn, J A Wells, et al.
International Journal of Radiation Biology|April 17, 2001
Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear--quadratic formulationA A Flynn, R B Pedley, A J Green, et al.
Nanoscale Advances|September 22, 2022
Enhanced efficacy in drug-resistant cancer cells through synergistic nanoparticle mediated delivery of cisplatin and decitabineM Parhizkar, P J T Reardon, A H Harker, et al.
Cancer Research|August 27, 1999
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agentR B Pedley, S K Sharma, G M Boxer, et al.
The British Journal of Radiology|January 1, 1991
Selective uptake of toxic nucleoside (125IUdR) by resistant cancerK D Bagshawe, K Sharma, P J Southall, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Cancer Research|April 28, 2001
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complexS P Cooke, G M Boxer, L Lawrence, et al.
British Journal of Cancer|April 17, 1999
In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell linesR A Al-Mufti, R B Pedley, D Marshall, et al.
Cancer Research|July 15, 1996
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agentsR B Pedley, J A Boden, R Boden, et al.
Protein Engineering, Design & Selection : PEDS|February 20, 2009
Data standards for minimum information collection for antibody therapy experimentsM Yong, B Tolner, S Nagl, et al.
British Journal of Cancer|June 13, 2001
Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical materialS D Webley, R J Francis, R B Pedley, et al.
NMR in Biomedicine|December 19, 2014
Hepatic arterial spin labelling MRI: an initial evaluation in miceR Ramasawmy, A E Campbell-Washburn, J A Wells, et al.
International Journal of Radiation Biology|April 17, 2001
Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear--quadratic formulationA A Flynn, R B Pedley, A J Green, et al.
Nanoscale Advances|September 22, 2022
Enhanced efficacy in drug-resistant cancer cells through synergistic nanoparticle mediated delivery of cisplatin and decitabineM Parhizkar, P J T Reardon, A H Harker, et al.
Cancer Research|August 27, 1999
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agentR B Pedley, S K Sharma, G M Boxer, et al.
The British Journal of Radiology|January 1, 1991
Selective uptake of toxic nucleoside (125IUdR) by resistant cancerK D Bagshawe, K Sharma, P J Southall, et al.
Pageof 8